Recent preclinical work 80 has begun to elucidate the underlying mechanisms of cognitive impairments following SCI, such as neuroinflammation in the brain, distal release of a potent microglial activators (i.e., CCL21) through anterograde and retrograde pathways, or systemic immune dysfunction. This evidence concerns the gene CCL21 and immune system disorder.